Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

7.88
Delayed Data
As of Jun 28
 +0.09 / +1.16%
Today’s Change
5.05
Today|||52-Week Range
9.17
+0.13%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
AssetsCash1.9M4.8M33.7M23.4M
 
 
 
 
 
Short Term Investment Cash-760.0K3.0M28.9M-10.3M
 
 
 
 
 
Cash & Short Term Investments1.9M4.8M33.7M23.4M
 
 
 
 
 
 
ReceivablesReceivables14.0M18.7M20.5M48.9M
 
 
 
 
 
 
InventoriesInventories1.9M2.3M2.6M5.1M
 
 
 
 
 
 
Current AssetsPrepaid Expenses820.0K1.1M1.1M4.9M
 
 
 
 
 
Other Current Assets--588.0K821.0K16.7M
 
 
 
 
Current Assets18.6M27.5M58.7M99.0M
 
 
 
 
 
 
Total AssetsProperty, Plant and Equipment - Gross18.9M24.2M34.9M61.1M
 
 
 
 
 
Depreciation-10.3M-14.5M-19.8M-26.5M
 
 
 
 
 
Intangible Assets2.8M2.6M7.1M234.2M
 
 
 
 
 
Other Assets2.9M2.7M7.3M234.4M
 
 
 
 
 
Total Assets30.1M39.9M81.1M368.0M
 
 
 
 
 
 
LiabilitiesAccounts Payable3.6M4.2M6.3M12.5M
 
 
 
 
 
Short Term Debt10.7M7.1M3.2M14.0M
 
 
 
 
 
Accrued Expenses669.0K741.0K1.2M7.4M
 
 
 
 
 
Other Current Liabilities669.0K741.0K1.2M7.4M
 
 
 
 
 
Other Liabilities17.8M14.3M14.6M40.1M
 
 
 
 
 
 
Total LiabilitiesLong Term Debt3.1M3.3M5.3M57.4M
 
 
 
 
 
Deferred Taxes0.00-588.0K-821.0K-32.4M
 
 
 
 
Total Liabilities20.9M18.2M20.7M129.8M
 
 
 
 
 
 
EquityMinority Interest0.000.000.000.00--
Preferred Stock0.000.000.0028.6M
 
 
Common Equity9.2M21.7M60.4M209.5M
 
 
 
 
 
Total Shareholder Equity9.2M21.7M60.4M238.1M
 
 
 
 
 
 
Share InformationCommon Shares Outstanding45.3M49.1M60.2M75.8M
 
 
 
 
 
 
Addtl. Info.No data currently available for this section.